Vertex Pharmaceuticals Incorporated · NASDAQ:VRTX
Capital Research Global Investors reported a 6.80% stake in Vertex Pharmaceuticals Incorporated (Schedule 13G/A)
Event Dec 31, 2025 · Filed Feb 12, 2026
Capital Research Global Investors reported a 6.80% stake in Vertex Pharmaceuticals Incorporated, 17,319,044 shares, as a passive investor on Dec 31, 2025. Filed Feb 12, 2026 (Schedule 13G/A).
- Stake
- 6.80%
- Shares
- 17,319,044
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Capital Research Global Investors | 6.80% | 17,319,044 |
Source
Related
- Vertex Pharmaceuticals Incorporated
- Capital Research Global Investors
- Vertex Pharmaceuticals Incorporated shareholders
- Schedule 13G/A · Capital Research Global Investors · May 14, 2026
- Schedule 13G · Capital Research Global Investors · May 13, 2025
- Form 4 · Brennan Daniel J. · Oct 22, 2026
- Form 4 · van Grunsven Jasper · Sep 10, 2026
- Form 4 · Ambrose Kristen · Sep 1, 2026
- Form 4 · Sachs Bruce I · Aug 31, 2026
- Form 4 · Tatsis Ourania · Jul 23, 2026